EN IT

Recursion Pharmaceuticals: double bottom forming, yet the decline holds

Week 5 of the sell signal on Recursion Pharmaceuticals: the stock closed up 9% on the week, but the technical setup remains mixed — distribution underway, resistances rejected, and a double bottom yet to confirm a reversal.

Recursion Pharmaceuticals: double bottom forming, yet the decline holds
Ongoing decline · week 5
Recursion Pharmaceuticals: double bottom forming, yet the decline holds
June 26, 2026
Ongoing decline · week 5
In Summary
Recursion Pharmaceuticals is in week 5 of a sell signal, with the trade down 17%. The week just closed sharply higher — buy volume at 81% — but distribution indicators remain active and key resistances continued to reject price. A case to monitor closely week by week.
Ongoing decline ·5th week from start ·US stocks ·T2 ★ See Gold version →
IQS Phase
44
ordinary
Signal Strength
2
indecisive week
Sizing
MINIMUM
Ranking
#124 / 131
US stocks
Trade P&L %
-16.94%
from signal to today
Chart · Weekly — EMA50 · MACD · VWAP
Weekly chart · EMA50 · MACD · VWAP · Source: TradingView
How to read this pageA visual guide to the post, card by card
The full analysis, operating plan and detailed levels on this asset are reserved for clients ★ PLATINUM
restricted Platinum content
Share WhatsApp Telegram Gmail LinkedIn